The pharma sector, once considered a safe bet, has been trailing the benchmark indices for four years in a row
The country accounts for 44% of overall revenues
While valuations are attractive, disruption will keep volumes muted
Analysts expect dent in near-term profits
Brokerages have cut their advertising and earnings estimates for broadcasters by up to 11 per cent
If the pandemic continues, a fifth of annual revenues could get affected
Higher share of replacement segment should help cushion demand drop
Motherson Sumi, Apollo Tyres and Tata Motors to be among the worst affected because of high exposure
Sharp fall in crude oil prices, however, is a positive
Hotel stocks are under pressure because the coronavirus outbreak could impact occupancies and, thus, drive down room tariffs
The development comes as passenger growth - which has been slowing down on account of the economic slowdown - has taken further hit due to the outbreak of coronavirus
Trading at 30x its FY21 earnings, there is limited upside
Completion of capex, improving prospects among positives
Valuation of over 13 times its FY21 estimated earnings reasonable
Exports - accounting for 43% of volumes - rose 7%, which helped offset the slowdown in the domestic segment. Domestic sales fell 13%, largely on account of the sharp 16%
Despite a high base of last year, the company was able to post a same-store sales growth of 9.2%. The metric a year ago was 14.7%
Prestige, Sobha top picks given their exposure to Bengaluru, other southern markets
Expansion, raising share of B2C network to help improve margins
Slow pace of new contracts remains a concern despite revenue growth
Investors should await signs of margin improvement and volume uptick, especially in the Prestige-and-above segment before considering investment in USL